At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Riboflavin supplementationdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Riboflavin Supplementation on Faecalibacterium Prausnitzii in Crohn's Disease
In Brief
A clinical study evaluating Riboflavin supplementation for Crohn Disease. Completed, enrolled 70 participants across 1 site.
Detailed Summary
This study will evaluate if suppelementation of the diet with riboflavin in Crohn's disease patients will result in an increase in the amount of F. prausnitzii.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCrohn Disease
CountriesNetherlands
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 2015
Enrollment StartMar 2016
Primary CompletionApr 2017
TodayJul 2026
First PostedSep 2, 2015
Enrollment StartMar 1, 2016
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 10.8 years ago
Interventions
Riboflavin supplementationdietary
Supplementation of the normal diet with 1 capsule of 100 mg riboflavin (vitamin B2) during three weeks